Skip to content
S8097Senate2023-2024 SessionSame asA9020

Study Blood Clot Risks

Official title

“Establishes a blood clot and pulmonary embolism policy workgroup”

Sponsor Roxanne J. PersaudSD-19+1 co-sponsorAffects Health
Status
In Assembly Committee
Health
Impact
4/10
Low
Passage
0%

Bill progress

Step 5 of 7

In Assembly · Health

What's happening

This bill creates a workgroup to study blood clots and pulmonary embolisms in New York and recommend policy improvements.

Why it matters

  1. Brings together a diverse group. including healthcare providers, patients, family members, and advocates—to examine blood clot and pulmonary embolism issues, ensuring that a wide range of perspectives and lived experiences inform policy recommendations.

  2. Targets gaps in data and care. by requiring the workgroup to identify how cases are tracked, current standards of care, and the impact on patients, which could reveal weaknesses or inconsistencies in existing systems.

  3. Aims to improve prevention and awareness. by recommending risk surveillance systems, better patient/family education, and enhanced detection protocols in healthcare facilities, potentially reducing preventable illnesses and deaths.

  4. Mandates accountability and transparency. through a required public report and official publication of recommendations, increasing pressure on state health officials and lawmakers to act on findings.

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Who cares

  • New York State Department of Health

    The commissioner would establish the workgroup, appoint its chair and publish its recommendations on the department’s website.

  • Blood clot survivors and bereaved families

    They would be represented on a workgroup examining patient impacts and recommending improvements to risk awareness and written risk notices.

  • Health care providers

    The workgroup would develop a risk surveillance system to help providers identify high-risk patients and recommend policies affecting standards of care.

  • Hospitals, nursing homes and other licensed health care facilities

    The workgroup would recommend ways to improve surveillance and detection of patients at higher risk of blood clots in these settings.

Headline styles

Study Blood Clot Risks

Plain English, a few words. Used as the page title.

Sponsors

Primary sponsor
Roxanne J. Persaud

Senator · Senate District 19

Chair, Social Services

1 Co-sponsor

History

  1. Referred to health
  2. Delivered to assembly
  3. Passed senateVote 61–0
  4. Amended on third reading 8097a
  5. Ordered to third reading cal.1494
  6. Committee discharged and committed to rules
  7. Referred to health

Companion bill

The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.

A9020Assembly

Create Blood Clot Policy Group

In Assembly Committee · Health · Sponsor Michaelle C. Solages

Impact 4 · Low0% to pass

Full text

2 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗

STATE OF NEW YORK

8097--A Cal. No. 1494

IN SENATE

January 8, 2024

Introduced by Sens. PERSAUD, MURRAY -- read twice and ordered printed, and when printed to be committed to the Committee on Health -- committee discharged and said bill committed to the Committee on Rules -ordered to a third reading, amended and ordered reprinted, retaining its place in the order of third reading

AN ACT to amend the public health law, in relation to establishing a blood clot and pulmonary embolism policy workgroup; and providing for the repeal of such provisions upon expiration thereof

The People of the State of New York, represented in Senate and Assembly, do enact as follows:

Section 1. Section 206 of the public health law is amended by adding a new subdivision 32 to read as follows:

32. (a) The commissioner shall establish a blood clot and pulmonary embolism policy workgroup. The workgroup shall be composed of health care providers, patients who have experienced blood clots, family members of patients who have died from blood clots, advocates, and other interested parties and associations. The governor, the temporary president of the senate and the speaker of the assembly shall each appoint two members to the workgroup. The commissioner shall appoint the chair of the workgroup.

(b) Members of the workgroup shall receive no compensation for their services, but may be paid their actual and necessary expenses incurred in serving the workgroup.

(c) It shall be the duty of the workgroup to study and issue recommendations pertaining to the incidence and treatment of blood clots and pulmonary embolisms within the state. The workgroup shall:

(i) Identify the aggregate number of people who experience blood clots and pulmonary embolisms each year in this state.

(ii) Identify how data is collected regarding blood clots, pulmonary embolisms, and adverse health outcomes associated with these conditions.

(iii) Identify how blood clots and pulmonary embolisms impact the lives of people in this state.

(iv) Identify the standards of care for blood clot surveillance, detection, and treatment.

EXPLANATION--Matter in italics (underscored) is new; matter in brackets

[ ] is old law to be omitted.

LBD13187-02-4

(v) Identify emerging treatments, therapies, and research relating to blood clots.

(vi) Develop a risk surveillance system to help health care providers identify patients who may be at a higher risk of forming blood clots and pulmonary embolisms.

(vii) Develop policy recommendations to help improve patient awareness of blood clot risks.

(viii) Develop policy recommendations to help improve surveillance and detection of patients who may be at a higher risk of forming blood clots in licensed health care facilities, including hospitals, nursing homes, assisted living facilities, residential treatment facilities, and ambulatory surgical centers.

(ix) Develop policy recommendations relating to guidelines used that affect the standard of care for patients at risk of forming blood clots.

(x) Develop policy recommendations relating to providing patients and their families with written notice of increased risks of forming blood clots.

(d) The chair is authorized to create subcommittees to help with research, scheduling speakers on important subjects, and drafting a workgroup report and policy recommendations.

(e) No later than one year after the effective date of this subdivision, the workgroup shall submit their recommendations in the form of a written report to the commissioner, the speaker of the assembly, the temporary president of the senate, the minority leader of the assembly and the minority leader of the senate.

(f) Upon receipt of the workgroup's report, the commissioner shall publish such recommendations on the department's website.

§ 2. This act shall take effect on the ninetieth day after it shall have become a law and shall expire and be deemed repealed two years and ninety days after it shall have become a law.

Reflowed for reading: line numbers and page breaks removed. Cite the official text.

Sponsor's memo

Title of bill

An act to amend the public health law, in relation to establishing a blood clot and pulmonary embolism policy workgroup; and providing for the repeal of such provisions upon expiration thereof

Purpose

To establish a blood clot policy workgroup which would ultimately raise awareness of blood clots, treatments, and policy solutions to dispari- ties in accessing such treatments.

Summary of provisions

Section. 1 of the bill amends section 206 of the public health law to add a new subdivision 32, which would direct the commissioner of health to establish a blood clot and pulmonary embolism policy workgroup. The workgroup shall be composed of two members appointed by the Temporary President of the Senate, two members appointed by the Speaker of the Assembly, two members appointed by the Governor, and a chair appointed by the commissioner. Such members shall be health care providers, patients who have experienced blood clots, family members of patients who have died from blood clots, advocates, and other interested parties. The workgroup shall identify the number of people in the state who expe- rience blood clots each year, identify how such data is collected, develop policy recommendations, among other related work. The workgroup shall submit their recommendations no later than one year after the affective date of this subdivision and upon receipt the commissioner shall publish the recommendations on the department's website.

Section 2 of the bill sets the effective date.

Justification

According to the National Blood Clot Alliance, on average, 274 people die each day from blood clots, amounting to 1 person every 6 minutes. Despite this, blood clots and their causes are understudied, and policy solutions remain underdeveloped and unexplored. A policy workgroup composed of relevant experts and stakeholders would go far in raising awareness of blood clots and exploring methods of reducing their frequency on a large scale.

Legislative history

New bill.

Fiscal impact on the state

To be determined.

Effective date

This act shall take effect on the ninetieth day after it shall have become a law and shall expire and be deemed repealed two years and nine- ty days after it shall have become a law.

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.